NMT2 Inhibitors

NMT2 inhibitors are a class of compounds that interact with the N-myristoyltransferase 2 enzyme, which is responsible for the attachment of myristic acid to the N-terminal glycine residue of substrate proteins. This post-translational modification is essential for the proper function and localization of various proteins within the cell. Inhibitors of NMT2 can operate by various mechanisms, including competitive inhibition by mimicking the natural substrates of the enzyme, such as myristic acid or peptide substrates. For instance, 2-hydroxymyristic acid resembles myristic acid and can bind to the active site of NMT2, preventing the enzyme from interacting with its true substrate. Tetradecylthioacetic acid, due to its structural similarity to myristic acid, could also act in a similar fashion.

In addition, other compounds may inhibit NMT2 indirectly by interfering with pathways related to lipid modification processes or by altering the cellular concentrations of substrates necessary for NMT2 activity. For example, cerulenin, an inhibitor of fatty acid synthase, could reduce the intracellular levels of myristic acid, thereby limiting the availability of this substrate for NMT2. Tipifarnib and manumycin A, which inhibit farnesyltransferase and farnesylation, respectively, could disrupt cellular processes related to lipid modifications, thereby possibly alteringNMT2 activity. Other compounds like tunicamycin could affect NMT2 indirectly by disrupting glycosylation, which may impact enzyme functionality. The inhibition of NMT2 through indirect pathways can be achieved by targeting associated biological processes and signaling pathways.